| __timestamp | Exelixis, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 189101000 | 19586000 |
| Thursday, January 1, 2015 | 96351000 | 29135000 |
| Friday, January 1, 2016 | 95967000 | 42791000 |
| Sunday, January 1, 2017 | 112171000 | 49577000 |
| Monday, January 1, 2018 | 182257000 | 89209000 |
| Tuesday, January 1, 2019 | 336964000 | 69099000 |
| Wednesday, January 1, 2020 | 547851000 | 75961000 |
| Friday, January 1, 2021 | 693716000 | 90467000 |
| Saturday, January 1, 2022 | 891813000 | 74552000 |
| Sunday, January 1, 2023 | 1044071000 | 91593000 |
| Monday, January 1, 2024 | 910408000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical landscape, innovation is the key to staying ahead. Exelixis, Inc. and Supernus Pharmaceuticals, Inc. have been at the forefront of this race, with their research and development (R&D) spending reflecting their commitment to innovation. Over the past decade, Exelixis has consistently outpaced Supernus in R&D investment, with a staggering 1,000% increase from 2014 to 2023. In contrast, Supernus has shown a more modest growth of around 370% in the same period. This significant difference highlights Exelixis's aggressive strategy to prioritize innovation, potentially leading to groundbreaking treatments and therapies. As the industry continues to grow, the focus on R&D will be crucial for these companies to maintain their competitive edge and deliver value to patients worldwide.
R&D Insights: How Sanofi and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Exelixis, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Supernus Pharmaceuticals, Inc. Allocate Funds
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Veracyte, Inc. or Supernus Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.